GW&K Investment Management LLC bought a new stake in shares of UnitedHealth Group Inc (NYSE:UNH) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 188,034 shares of the healthcare conglomerate’s stock, valued at approximately $46,843,000. UnitedHealth Group makes up approximately 0.9% of GW&K Investment Management LLC’s investment portfolio, making the stock its 19th largest holding.
Other institutional investors have also made changes to their positions in the company. Advisor Partners LLC boosted its holdings in UnitedHealth Group by 6.5% in the fourth quarter. Advisor Partners LLC now owns 31,893 shares of the healthcare conglomerate’s stock worth $7,945,000 after acquiring an additional 1,949 shares in the last quarter. TIAA CREF Investment Management LLC boosted its holdings in UnitedHealth Group by 7.3% in the third quarter. TIAA CREF Investment Management LLC now owns 5,462,680 shares of the healthcare conglomerate’s stock worth $1,453,291,000 after acquiring an additional 370,179 shares in the last quarter. Financial Enhancement Group LLC boosted its holdings in UnitedHealth Group by 2,579.3% in the third quarter. Financial Enhancement Group LLC now owns 1,554 shares of the healthcare conglomerate’s stock worth $413,000 after acquiring an additional 1,496 shares in the last quarter. Legacy Bridge LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $824,000. Finally, LS Investment Advisors LLC boosted its holdings in UnitedHealth Group by 38.9% in the fourth quarter. LS Investment Advisors LLC now owns 34,921 shares of the healthcare conglomerate’s stock worth $8,700,000 after acquiring an additional 9,784 shares in the last quarter. Institutional investors own 85.80% of the company’s stock.
Shares of UNH opened at $251.40 on Friday. The company has a debt-to-equity ratio of 0.64, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $243.06 billion, a P/E ratio of 19.52, a price-to-earnings-growth ratio of 1.26 and a beta of 0.79. UnitedHealth Group Inc has a 12 month low of $212.49 and a 12 month high of $287.94.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 15th. The healthcare conglomerate reported $3.28 EPS for the quarter, beating the Zacks’ consensus estimate of $3.20 by $0.08. The company had revenue of $58.42 billion during the quarter, compared to the consensus estimate of $58.01 billion. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. UnitedHealth Group’s revenue was up 12.2% on a year-over-year basis. During the same period last year, the business posted $2.59 earnings per share. On average, equities research analysts predict that UnitedHealth Group Inc will post 14.62 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 19th. Investors of record on Monday, March 11th will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Friday, March 8th. UnitedHealth Group’s payout ratio is 27.95%.
In related news, Director Richard T. Burke sold 5,000 shares of the stock in a transaction that occurred on Tuesday, March 12th. The stock was sold at an average price of $245.01, for a total transaction of $1,225,050.00. Following the completion of the sale, the director now directly owns 182,372 shares of the company’s stock, valued at $44,682,963.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 2,930 shares of the stock in a transaction that occurred on Thursday, March 14th. The shares were sold at an average price of $253.39, for a total value of $742,432.70. Following the sale, the director now directly owns 64,726 shares of the company’s stock, valued at $16,400,921.14. The disclosure for this sale can be found here. Insiders have sold 27,930 shares of company stock valued at $7,208,783 over the last ninety days. 0.87% of the stock is currently owned by company insiders.
Several brokerages have issued reports on UNH. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, November 29th. Oppenheimer raised their target price on UnitedHealth Group from $295.00 to $300.00 and gave the company an “outperform” rating in a report on Wednesday, November 28th. Raymond James set a $310.00 target price on UnitedHealth Group and gave the company a “buy” rating in a report on Wednesday, November 28th. Piper Jaffray Companies raised their target price on UnitedHealth Group to $312.00 and gave the company an “overweight” rating in a report on Wednesday, November 28th. Finally, BMO Capital Markets set a $310.00 target price on UnitedHealth Group and gave the company a “buy” rating in a report on Tuesday, November 27th. Two equities research analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average price target of $297.80.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: What factors cause inflation to rise?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.